|
RNPS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.255520E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.915900E-02 |
| Normal-vs-Stage2 |
1.264600E-01 |
| Normal-vs-Stage3 |
1.405580E-01 |
| Normal-vs-Stage4 |
5.070200E-02 |
| Stage1-vs-Stage2 |
5.462800E-01 |
| Stage1-vs-Stage3 |
8.920000E-01 |
| Stage1-vs-Stage4 |
3.444800E-01 |
| Stage2-vs-Stage3 |
6.778800E-01 |
| Stage2-vs-Stage4 |
8.189600E-01 |
| Stage3-vs-Stage4 |
4.844800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.395800E-03 |
| Normal-vs-AfricanAmerican |
7.722200E-02 |
| Normal-vs-Asian |
2.504200E-01 |
| Caucasian-vs-AfricanAmerican |
3.976800E-01 |
| Caucasian-vs-Asian |
4.308400E-01 |
| AfricanAmerican-vs-Asian |
2.737000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.159700E-02 |
| Normal-vs-Female |
2.762200E-02 |
| Male-vs-Female |
6.561200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.994000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.648100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.614400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.567840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.851400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.242800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.441800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.488400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.489600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.723400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.537800E-03 |
| Classical-VS-Follicular |
6.460300E-02 |
| Classical-VS-Other |
4.943400E-01 |
| Classical-VS-Normal |
3.586800E-04 |
| Tall-VS-Follicular |
3.211800E-01 |
| Tall-VS-Other |
5.083600E-01 |
| Tall-VS-Normal |
3.835600E-01 |
| Follicular-VS-Other |
9.510400E-01 |
| Follicular-VS-Normal |
7.155400E-01 |
| Other-VS-Normal |
8.117600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.323800E-02 |
| Normal-vs-N1 |
8.501400E-01 |
| N0-vs-N1 |
1.378780E-01 |
|
|
